Psychiatry
Adult ADHD Diagnosis
NICE NG87 — DSM-5 / ICD-11 criteria, structured interview (DIVA), exclude differentials, multimodal management (psychostimulants + non-pharm).
Source: NICE NG87 (2018)
Step 1 of ~3
info
Adult Presentation + Diagnostic Process
Persistent (≥6 months) + cross-setting (work + home) symptoms of inattention and/or hyperactivity-impulsivity, with onset in childhood (DSM-5: before age 12; ICD-11: childhood onset). Symptom domains: difficulty organising tasks, easily distracted, restless, talkative, impulsive decisions, emotional dysregulation. Functional impairment in work, education, relationships.
Use structured assessment: Diagnostic Interview for ADHD (DIVA-5) + collateral (school reports if available, family informant). Screen with ASRS (≥4/6 part A suggestive).
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Sodium Chloride 3% (Hypertonic Saline) · Hypertonic Electrolyte Solution — ICP/Hyponatraemia Management
- Methotrexate (Ectopic) · Antimetabolite (Ectopic Pregnancy Management)
- Lissamine Green 1% Eye Drops · Vital Dye — Ocular Surface Staining (Dry Eye Diagnosis)
- Atomoxetine · Selective Noradrenaline Reuptake Inhibitor (SNRI) — ADHD (Non-Stimulant)
- Sildenafil (Paediatric — PPHN / PAH) · PDE5 Inhibitor (Paediatric Pulmonary Hypertension)
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185
Decision support only. Always apply local guidelines and clinical judgement.